Bedaquiline

Results: 15



#Item
1FOR IMMEDIATE RELEASE STREAM CLINICAL STUDY FIRST TO INCLUDE BEDAQUILINE TO TEST SHORTENED TREATMENT REGIMENS FOR MULTIDRUG-RESISTANT TB IN PHASE III TRIAL Stage 2 of trial aims to reduce MDR-TB treatment from 24 months

FOR IMMEDIATE RELEASE STREAM CLINICAL STUDY FIRST TO INCLUDE BEDAQUILINE TO TEST SHORTENED TREATMENT REGIMENS FOR MULTIDRUG-RESISTANT TB IN PHASE III TRIAL Stage 2 of trial aims to reduce MDR-TB treatment from 24 months

Add to Reading List

Source URL: www.theunion.org

- Date: 2016-04-14 03:33:49
    2Embargoed: 12 May – 1130 hrs CEST WORLD HEALTH ORGANIZATION RECOMMENDS SHORTENED NINE-MONTH TREATMENT REGIMEN FOR MDR-TB PATIENTS

    Embargoed: 12 May – 1130 hrs CEST WORLD HEALTH ORGANIZATION RECOMMENDS SHORTENED NINE-MONTH TREATMENT REGIMEN FOR MDR-TB PATIENTS

    Add to Reading List

    Source URL: www.theunion.org

    Language: English - Date: 2016-05-12 09:07:39
    3NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health Laboratory Service South African Tuberculosis Drug Resistance Survey

    NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health Laboratory Service South African Tuberculosis Drug Resistance Survey

    Add to Reading List

    Source URL: www.nicd.ac.za

    Language: English - Date: 2016-07-13 09:09:48
    4301030_dec14-CSUmatters_113.indd

    301030_dec14-CSUmatters_113.indd

    Add to Reading List

    Source URL: www.president.colostate.edu

    Language: English - Date: 2014-12-29 15:39:02
    52014 A Review of the Bedaquiline Patent Landscape A scoping report JANUARY  2014

    2014 A Review of the Bedaquiline Patent Landscape A scoping report JANUARY  2014

    Add to Reading List

    Source URL: www.unitaid.org

    Language: English - Date: 2014-01-23 08:24:29
      6Division of TB Elimination Reference Laboratory Instructions for U.S. Public Health Laboratory Submission of Mycobacterium tuberculosis Complex Isolates for Phenotypic Drug Susceptibility Testing of Bedaquiline for the

      Division of TB Elimination Reference Laboratory Instructions for U.S. Public Health Laboratory Submission of Mycobacterium tuberculosis Complex Isolates for Phenotypic Drug Susceptibility Testing of Bedaquiline for the

      Add to Reading List

      Source URL: centerfortuberculosis.mayo.edu

      Language: English
        72014 A Review of the Bedaquiline Patent Landscape A scoping report JANUARY  2014

        2014 A Review of the Bedaquiline Patent Landscape A scoping report JANUARY  2014

        Add to Reading List

        Source URL: unitaid.org

        Language: English - Date: 2014-01-23 08:24:29
          8Introduction of bedaquiline for the treatment of multidrug-resistant tuberculosis at country level Implementation plan

          Introduction of bedaquiline for the treatment of multidrug-resistant tuberculosis at country level Implementation plan

          Add to Reading List

          Source URL: www.who.int

          Language: English - Date: 2015-04-01 05:19:15
          9Clinical Commissioning Policy: Bedaquiline and Delamanid for defined patients with MDR-XDR-TB 1 Reference: NHS England xxx/x/x

          Clinical Commissioning Policy: Bedaquiline and Delamanid for defined patients with MDR-XDR-TB 1 Reference: NHS England xxx/x/x

          Add to Reading List

          Source URL: www.engage.england.nhs.uk

          Language: English - Date: 2015-03-24 05:27:50
          10TB EliminationTreatment of Multidrug-Resistant Tuberculosis: Bedaquiline

          TB EliminationTreatment of Multidrug-Resistant Tuberculosis: Bedaquiline

          Add to Reading List

          Source URL: www.cdc.gov

          Language: English - Date: 2014-12-24 13:25:45